Regulation of p38 MAPK by MAPK kinases 3 and 6 in fibroblast-like synoviocytes

被引:62
作者
Inoue, T [1 ]
Hammaker, D [1 ]
Boyle, DL [1 ]
Firestein, GS [1 ]
机构
[1] Univ Calif San Diego, Sch Med, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA
关键词
D O I
10.4049/jimmunol.174.7.4301
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The p38 MAPK signal transduction pathway is a key regulator of IL-1 and TNF-alpha production in rheumatoid arthritis. Previous studies demonstrated that upstream MAPK kinases (MKK3 and MKK6) that regulate p38 are activated in rheumatoid arthritis synovium. However, their functional relevance in fibroblast-like synoviocytes (FLS) has not been determined. To investigate the relative contribution of MKK3 and MKK6 to p38 activation, the effect of dominant-negative (DN) MKK3 and MKK6 constructs on cultured FLS was evaluated. Cultured FLS were stimulated with medium or IL-1 beta, and immunoblotting was performed. In some experiments, cells were lysed and immunoprecipitated with anti-p38 Ab, followed by in vitro kinase assay with [gamma-P-32]ATP and GST-activating transcription factor-2 as substrate. IL-1 beta rapidly induced p38 phosphorylation in cells transfected with empty vector (pcDNA3.1), but was inhibited by 25% in cells expressing DN MKK3 or DN MKK6. Cotransfection with both DN plasmids decreased phospho-p38 by almost 75%. In vitro kinase assays on IL-1-stimulated FLS also showed that the combination of DN MKK3 and DN MKK6 markedly decreased kinase activity compared with empty vector or the individual DN plasmids. Furthermore, IL-1 beta-induced IL-8, IL-6, and matrix metalloproteinase-3 protein production was significantly inhibited in DN MKK3/DN AIKK6-transfected cells. The constructs had no effect on the respective mediator mRNA levels. These data demonstrate that MKK3 and MKK6 make individual contributions to p38 activation in FLS after cytokine stimulation, but that both must be blocked for maximum inhibition.
引用
收藏
页码:4301 / 4306
页数:6
相关论文
共 43 条
  • [1] ALVAROGRACIA JM, 1991, J IMMUNOL, V146, P3365
  • [2] THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS
    ARNETT, FC
    EDWORTHY, SM
    BLOCH, DA
    MCSHANE, DJ
    FRIES, JF
    COOPER, NS
    HEALEY, LA
    KAPLAN, SR
    LIANG, MH
    LUTHRA, HS
    MEDSGER, TA
    MITCHELL, DM
    NEUSTADT, DH
    PINALS, RS
    SCHALLER, JG
    SHARP, JT
    WILDER, RL
    HUNDER, GG
    [J]. ARTHRITIS AND RHEUMATISM, 1988, 31 (03): : 315 - 324
  • [3] Quantitative biomarker analysis of synovial gene expression by real-time PCR
    Boyle, DL
    Rosengren, S
    Bugbee, W
    Kavanaugh, A
    Firestein, GS
    [J]. ARTHRITIS RESEARCH & THERAPY, 2003, 5 (06) : R352 - R360
  • [4] Mechanism of p38 MAP kinase activation in vivo
    Brancho, D
    Tanaka, N
    Jaeschke, A
    Ventura, JJ
    Kelkar, N
    Tanaka, Y
    Kyuuma, M
    Takeshita, T
    Flavell, RA
    Davis, RJ
    [J]. GENES & DEVELOPMENT, 2003, 17 (16) : 1969 - 1978
  • [5] Expression and activation of mitogen-activated protein kinase kinases-3 and-6 in rheumatoid arthritis
    Chabaud-Riou, M
    Firestein, GS
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (01) : 177 - 184
  • [6] Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38
    Clark, AR
    Dean, JLE
    Saklatvala, J
    [J]. FEBS LETTERS, 2003, 546 (01): : 37 - 44
  • [7] MEKKs, GCKs, MLKs, PAKs, TAKs, and Tpls: Upstream regulators of the c-Jun amino-terminal kinases?
    Fanger, GR
    Gerwins, P
    Widmann, C
    Jarpe, MB
    Johnson, GL
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 1997, 7 (01) : 67 - 74
  • [8] Evolving concepts of rheumatoid arthritis
    Firestein, GS
    [J]. NATURE, 2003, 423 (6937) : 356 - 361
  • [9] Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); Comparison of its substrate specificity with that of other SAP kinases
    Goedert, M
    Cuenda, A
    Craxton, M
    Jakes, R
    Cohen, P
    [J]. EMBO JOURNAL, 1997, 16 (12) : 3563 - 3571
  • [10] Hale KK, 1999, J IMMUNOL, V162, P4246